Binedaline

Binedaline (also called binodaline or binedaline hydrochloride;[1]) is a drug that was investigated as an antidepressant in the 1980s but was never marketed.[2][3] It acts as a selective norepinephrine reuptake inhibitor (Ki = 25 nM), with relatively insignificant influence on the serotonin (Ki = 847 nM) and dopamine (Ki >= 2 μM) transporters.[4] It has negligible affinity for the α-adrenergic, mACh, H1, or 5-HT2 receptors.[4]

Binedaline
Clinical data
Routes of
administration		Oral
ATC code
  • None
Legal status
Legal status
  • In general: unscheduled
Identifiers
  • N,N,N-Trimethyl-N-(3-phenylindol-1-yl)ethane-1,2-diamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H23N3
Molar mass293.414 g·mol−1
3D model (JSmol)
  • c1cccc2c1c(cn2N(CCN(C)C)C)c3ccccc3
  • InChI=1S/C19H23N3/c1-20(2)13-14-21(3)22-15-18(16-9-5-4-6-10-16)17-11-7-8-12-19(17)22/h4-12,15H,13-14H2,1-3H3 checkY
  • Key:SXYFFMXPDDGOEK-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Synthesis
Thieme Synthesis:[5] Patents:[6][7]

Grignard reaction of 2-aminobenzophenone [2835-77-0] (1) with methylmagnesium bromide and dehydration of the tertiary carbinol gives 2-(1-phenylvinyl)aniline [64097-92-3] (2). In an example of the Widman‐Stoermer Synthesis, treatment with nitrous acid followed by basification of the diazonium species with ammonia causes an intramolecular cyclization to afford 4-phenylcinnoline [21874-06-6] (3). Hydrogenation would give 4-Phenyl-1,4-dihydrocinnoline, CID:14175750 (4). The presence of acetic acid gives (5). The reaction with Methyl p-toluenesulfonate [80-48-8] leads to CID:20337750 (6). Acid hydrolysis gives N-methyl-3-phenylindol-1-amine [57647-15-1] (7). Sodamide is then used to abstract the amine proton; alkylation of then anionic species with 2-dimethylaminoethylchloride [107-99-3] (8) then concludes the synthesis of binedaline (9).

See also

Widman‐Stoermer Synthesis also used for the synthesis of Cintazone [2056-56-6].

References
  1. Milne GW (2017). "3043: Binedaline hydrochloride". In Milne GW (ed.). Drugs: Synonyms and Properties. Routledge. ISBN 9781351755092.
  2. Faltus F, Geerling FC (1984). "A controlled double-blind study comparing binedaline and imipramine in the treatment of endogenous depression". Neuropsychobiology. 12 (1): 34–8. doi:10.1159/000118107. PMID 6239991.
  3. Triggle DJ (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
  4. Morin D, Zini R, Urien S, Tillement JP (April 1989). "Pharmacological profile of binedaline, a new antidepressant drug". The Journal of Pharmacology and Experimental Therapeutics. 249 (1): 288–96. PMID 2540319.
  5. Schatz, F.; Jahn, U.; Wagner-Jauregg, T.; Zirngibl, L.; Thiele, K. (1980). "1-amino-3-phenylindoles with antidepressant activity. Binodaline hydrochloride and related substances". Arzneimittel-Forschung. 30 (6): 919–923. doi:10.1002/chin.198038207. PMID 7191264.
  6. Franz Dr. Maria-Enzersdorf Ch Schatz, 6 More », DE2512702 (1982 to Siegfried Ag, Zofingen, Ch). idem GB 1502821 (compound #9).
  7. Franz Schatz, et al. U.S. Patent 4,204,998 (1980 to Siegfried AG).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.